ContextLogic Holdings Q1 net income jumps on tax benefit

LogicBio Therapeutics

LogicBio Therapeutics

LOGC

0.00


Overview

  • US niche business platform's Q1 revenue flat yr/yr after US Salt acquisition

  • Q1 net income rose sharply, driven by a $41.9 mln tax benefit from acquisition

  • Adjusted EBITDA for Q1 declined due to new parent-level costs


Outlook

  • Company did not provide specific financial guidance for the current quarter or full year in its release


Result Drivers

  • VOLUME DECLINE - Shipped volumes fell 7% due to trucking disruptions from winter storms and temporary operational interruptions at the Watkins Glen facility

  • HIGHER SELLING PRICES - 8% growth in average selling price offset lower volumes, driven by price increases and product mix shift

  • CORPORATE COSTS - Adjusted EBITDA declined due to approximately $1 mln of parent-level costs not present in the prior-year period


Company press release: ID:nGNX1rcsqZ


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q1 Revenue

$32.40 mln

Q1 Net Income

$17 mln

Q1 Adjusted EBITDA

$11.60 mln


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.